Literature DB >> 17712626

The role of TNF-alpha and its receptors in the production of beta-1,4-galactosyltransferase I mRNA by rat primary type-2 astrocytes.

Meijuan Yan1, Chunlin Xia, Shuqiong Niu, Chun Cheng, Xiaoyi Shao, Aiguo Shen.   

Abstract

beta-1,4-galactosyltransferase I (beta-1,4-GalT I) plays an important role in the synthesis of the backbone structure of adhesion molecules involved in leukocyte-endothelial cell interaction. The expression of beta-1,4-GalT I mRNA increased in primary human endothelial cells after exposure to tumor necrosis factor-alpha (TNF-alpha). In the central nervous system (CNS), astrocytes play a pivotal role in immunity as immunocompetent cells by secreting cytokines and inflammatory mediators, there are two types of astrocytes. Type-1 astrocytes can secrete TNF-alpha when stimulated with Lipopolysaccharide (LPS), while the responses of type-2 astrocytes during inflammation are unknown. So we examined the expression change of beta-1,4-GalT I mRNA in type-2 astrocytes after exposure to TNF-alpha and LPS. Real-time PCR showed that TNF-alpha or LPS affected beta-1,4-GalT I mRNA expression in a time- and dose-dependent manner. RT-PCR analysis revealed that TNFR1 and TNFR2 were present in normal untreated type-2 astrocytes, and that TNF-alpha, TNFR1 and TNFR2 increased in type-2 astrocytes after exposure to TNF-alpha or LPS. Immunocytochemistry showed that TNFR1 was expressed in the cytoplasm, nucleus and processes of normal untreated type-2 astrocytes, and distributed mainly in the cytoplasm and processes after exposure to LPS. TNFR2 was mainly expressed in the nucleus of normal untreated type-2 astrocytes, and distributed mainly in the processes of type-2 astrocytes after exposure to LPS. Both anti-TNFR1 and anti-TNFR2 antibodies suppressed beta-1,4-GalT I mRNA expression induced by TNF-alpha or LPS. From these results, we conclude that TNF-alpha signaling via both TNFR1 and TNFR2 translocated from nucleus to cytoplasm or processes is sufficient to induce beta-1,4-GalT I mRNA. In addition, we observed that not only exogenous TNF-alpha but also TNF-alpha produced by type-2 astrocytes affected beta-1,4-GalT I mRNA production in type-2 astrocytes. These results suggest that an autocrine loop involving TNF-alpha contributes to the production of beta-1,4-GalT I mRNA in response to inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712626     DOI: 10.1007/s10571-007-9182-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  25 in total

Review 1.  Cell surface galactosyltransferase: current issues.

Authors:  B D Shur; S Evans; Q Lu
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

2.  Autocrine activation of microglia by tumor necrosis factor-alpha.

Authors:  Reiko Kuno; Jinyan Wang; Jun Kawanokuchi; Hideyuki Takeuchi; Tetsuya Mizuno; Akio Suzumura
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

Review 3.  Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia.

Authors:  P L Wood
Journal:  Neurol Res       Date:  1995-08       Impact factor: 2.448

4.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.

Authors:  M C Raff; R H Miller; M Noble
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

5.  Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury.

Authors:  Albert Quintana; Mercedes Giralt; Santiago Rojas; Milena Penkowa; Iain L Campbell; Juan Hidalgo; Amalia Molinero
Journal:  J Neurosci Res       Date:  2005-12-01       Impact factor: 4.164

6.  Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library.

Authors:  N L Shaper; J H Shaper; J L Meuth; J L Fox; H Chang; I R Kirsch; G F Hollis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Monoclonal antibody to a plasma membrane antigen of neurons.

Authors:  G S Eisenbarth; F S Walsh; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Production of tumor necrosis factor-alpha by microglia and astrocytes in culture.

Authors:  M Sawada; N Kondo; A Suzumura; T Marunouchi
Journal:  Brain Res       Date:  1989-07-10       Impact factor: 3.252

9.  Sperm from beta 1,4-galactosyltransferase-null mice are refractory to ZP3-induced acrosome reactions and penetrate the zona pellucida poorly.

Authors:  Q Lu; B D Shur
Journal:  Development       Date:  1997-10       Impact factor: 6.868

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  4 in total

1.  Upregulation of β-1,4-galactosyltransferase I in rat spinal cord with experimental autoimmune encephalomyelitis.

Authors:  Jianmei Zhao; Ying Gao; Chun Cheng; Meijuan Yan; Jian Wang
Journal:  J Mol Neurosci       Date:  2012-06-16       Impact factor: 3.444

2.  β-1,4-galactosyltransferase I promotes tumor necrosis factor-α autocrine via the activation of MAP kinase signal pathways in Schwann cells.

Authors:  Huiguang Yang; Qin Yuan; Qian Chen; Chunmiao Li; Xiujie Wu; Chen Peng; Lihua Kang; Xiang Lu; Huiqing Sun; Zhengming Zhou; Aiguo Shen; Chun Cheng
Journal:  J Mol Neurosci       Date:  2011-04-02       Impact factor: 3.444

3.  Evidence for TNFα action on excitatory and inhibitory neurotransmission in the central amygdala: a brain site influenced by stress.

Authors:  Zhen Ming; Hugh E Criswell; George R Breese
Journal:  Brain Behav Immun       Date:  2013-06-11       Impact factor: 7.217

4.  Expression of fasciculation and elongation protein zeta-1 (FEZ1) in cultured rat neonatal astrocytes.

Authors:  Jianghong He; Jun Liu; Zhijun Zhang; Maomin Sun; Ting Zhu; Chunlin Xia
Journal:  Mol Cell Biochem       Date:  2009-02-08       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.